Velan Capital Investment Management LP - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 186 filers reported holding ADMA BIOLOGICS INC in Q4 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
Velan Capital Investment Management LP ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q1 2024$10,088,767
+4.5%
1,528,601
-28.4%
4.58%
-18.7%
Q4 2023$9,655,172
+55.3%
2,136,100
+23.0%
5.64%
+12.4%
Q3 2023$6,215,238
-38.2%
1,736,100
-36.3%
5.01%
-46.3%
Q2 2023$10,059,128
-24.0%
2,726,051
-31.8%
9.34%
-17.2%
Q1 2023$13,240,000
-14.7%
4,000,0000.0%11.29%
-17.7%
Q4 2022$15,520,000
+21.2%
4,000,000
-24.1%
13.71%
+8.0%
Q3 2022$12,804,000
+6.5%
5,269,155
-13.2%
12.70%
+4.1%
Q2 2022$12,026,000
+12.9%
6,073,598
+4.3%
12.20%
+23.4%
Q1 2022$10,656,000
+40.0%
5,822,798
+7.9%
9.89%
+67.4%
Q4 2021$7,611,0005,397,7985.91%
Other shareholders
ADMA BIOLOGICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Prosight Management, LP 883,214$1,722,0000.80%
Telemetry Investments, L.L.C. 200,615$391,0000.66%
Perceptive Advisors 16,584,802$32,340,0000.35%
Consonance Capital Management LP 1,558,290$3,039,0000.28%
683 Capital Management, LLC 2,000,000$3,900,0000.18%
ESSEX INVESTMENT MANAGEMENT CO LLC 627,931$1,224,0000.15%
GSA CAPITAL PARTNERS LLP 327,052$638,0000.10%
APOGEM CAPITAL LLC 54,240$106,0000.07%
HUSSMAN STRATEGIC ADVISORS, INC. 82,000$160,0000.04%
J. Goldman & Co LP 376,319$734,0000.04%
View complete list of ADMA BIOLOGICS INC shareholders